Organogenesis Holdings (ORGO) Gross Margin (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Gross Margin of 30.77% for Q1 2026, down 4186.0% year-over-year from 0.75% in Q1 2025, and down 60.48% quarter-over-quarter from 77.87% in Q4 2025.
Organogenesis Holdings (ORGO) Gross Margin (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Gross Margin history runs 10 years deep, the most recent figure standing at 30.77% for Q1 2026.
- In Q1 2026, Gross Margin fell 4186.0% year-over-year to 30.77%; the TTM figure through Mar 2026 stood at 72.88% (down 297.0% YoY), while the FY2025 annual figure was 75.62%, down 37.0% from the prior year.
- Gross Margin for Q1 2026 stood at 30.77%, down from 77.87% in the prior quarter.
- The five-year high for Gross Margin was 78.05% in Q2 2022, with the low at 30.77% in Q1 2026.
- The 5-year median for Gross Margin is 75.97% (2025), against an average of 73.01%.
- The sharpest annual moves came in 2024 and 2026: Gross Margin soared 335 bps in 2024, then plunged 4186 bps in 2026.
- Organogenesis Holdings' Gross Margin stood at 76.53% in 2022, then dropped by 6 bps to 72.13% in 2023, then advanced by 5 bps to 75.48% in 2024, then advanced by 3 bps to 77.87% in 2025, then tumbled by 60 bps to 30.77% in 2026.
- Business Quant data shows ORGO's Gross Margin at 30.77% in Q1 2026, 77.87% in Q4 2025, and 75.97% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 45.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.90% |
| Mar 31, 2026 | 30.77% |
| Dec 31, 2025 | 77.87% |
| Sep 30, 2025 | 75.97% |
| Jun 30, 2025 | 72.64% |
| Mar 31, 2025 | 72.64% |
| Dec 31, 2024 | 75.48% |
| Sep 30, 2024 | 76.73% |
| Jun 30, 2024 | 77.58% |
| Mar 31, 2024 | 73.91% |
| Dec 31, 2023 | 72.13% |
| Sep 30, 2023 | 76.24% |
| Jun 30, 2023 | 77.57% |
| Mar 31, 2023 | 75.28% |
| Dec 31, 2022 | 76.53% |
| Sep 30, 2022 | 77.60% |
| Jun 30, 2022 | 78.05% |
| Mar 31, 2022 | 74.18% |
| Dec 31, 2021 | 74.51% |
| Sep 30, 2021 | 77.00% |